Cargando…
Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016584/ https://www.ncbi.nlm.nih.gov/pubmed/33824628 http://dx.doi.org/10.1155/2021/6672400 |
_version_ | 1783673889436467200 |
---|---|
author | Matta, Anthony G. Lhermusier, Thibault Parada, Francisco Campelo Bouisset, Frederic Canitrot, Ronan Nader, Vanessa Blanco, Stéphanie Elbaz, Meyer Roncalli, Jerome Carrié, Didier |
author_facet | Matta, Anthony G. Lhermusier, Thibault Parada, Francisco Campelo Bouisset, Frederic Canitrot, Ronan Nader, Vanessa Blanco, Stéphanie Elbaz, Meyer Roncalli, Jerome Carrié, Didier |
author_sort | Matta, Anthony G. |
collection | PubMed |
description | INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI procedures. MATERIALS AND METHODS: A retrospective study was conducted on 1336 consecutive patients who underwent TAVI in Toulouse University Hospital, Rangueil, France. The studied population was divided into 2 groups: CAD-TAVI group and No CAD-TAVI group. Then, the CAD-TAVI group was segregated into 2 subgroups: PCI-TAVI group and No PCI-TAVI group. In-hospital adverse clinical outcomes were assessed in each group. RESULTS: Pre-TAVI work-up revealed significant CAD in 36% of 1030 patients eligible for inclusion in the study. The overall prevalence of in-hospital death, stroke, major or life-threatening bleeding, minor bleeding, major vascular complications, minor vascular complications, pacemaker implantation, and acute kidney injury was 2.7%, 2.4%, 2.8%, 3.6%, 3.9%, 7.5%, 12.5%, and 2.7%, respectively. Among the studied population, 55% were admitted to the cardiac care unit. No significant statistical difference was observed between groups. Discussion. CAD-TAVI population was not more likely to develop in-hospital adverse clinical outcomes post-TAVI procedure compared to others. Also, no significant difference regarding in-hospital death was observed. In parallel, performing PCI prior to TAVI did not increase the risk of in-hospital death and complications. The difference in terms of the distribution of antithrombotic regimen may explain the higher prevalence of bleeding events in the PCI-TAVI group. CONCLUSION: This study provides direct clinical relevance useful in daily practice. No negative impact has been attributed to the presence of a concomitant CAD and/or preoperative PCI on the TAVI hospitalization period. |
format | Online Article Text |
id | pubmed-8016584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-80165842021-04-05 Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation Matta, Anthony G. Lhermusier, Thibault Parada, Francisco Campelo Bouisset, Frederic Canitrot, Ronan Nader, Vanessa Blanco, Stéphanie Elbaz, Meyer Roncalli, Jerome Carrié, Didier J Interv Cardiol Research Article INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI procedures. MATERIALS AND METHODS: A retrospective study was conducted on 1336 consecutive patients who underwent TAVI in Toulouse University Hospital, Rangueil, France. The studied population was divided into 2 groups: CAD-TAVI group and No CAD-TAVI group. Then, the CAD-TAVI group was segregated into 2 subgroups: PCI-TAVI group and No PCI-TAVI group. In-hospital adverse clinical outcomes were assessed in each group. RESULTS: Pre-TAVI work-up revealed significant CAD in 36% of 1030 patients eligible for inclusion in the study. The overall prevalence of in-hospital death, stroke, major or life-threatening bleeding, minor bleeding, major vascular complications, minor vascular complications, pacemaker implantation, and acute kidney injury was 2.7%, 2.4%, 2.8%, 3.6%, 3.9%, 7.5%, 12.5%, and 2.7%, respectively. Among the studied population, 55% were admitted to the cardiac care unit. No significant statistical difference was observed between groups. Discussion. CAD-TAVI population was not more likely to develop in-hospital adverse clinical outcomes post-TAVI procedure compared to others. Also, no significant difference regarding in-hospital death was observed. In parallel, performing PCI prior to TAVI did not increase the risk of in-hospital death and complications. The difference in terms of the distribution of antithrombotic regimen may explain the higher prevalence of bleeding events in the PCI-TAVI group. CONCLUSION: This study provides direct clinical relevance useful in daily practice. No negative impact has been attributed to the presence of a concomitant CAD and/or preoperative PCI on the TAVI hospitalization period. Hindawi 2021-03-24 /pmc/articles/PMC8016584/ /pubmed/33824628 http://dx.doi.org/10.1155/2021/6672400 Text en Copyright © 2021 Anthony G. Matta et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Matta, Anthony G. Lhermusier, Thibault Parada, Francisco Campelo Bouisset, Frederic Canitrot, Ronan Nader, Vanessa Blanco, Stéphanie Elbaz, Meyer Roncalli, Jerome Carrié, Didier Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title | Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title_full | Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title_fullStr | Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title_full_unstemmed | Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title_short | Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation |
title_sort | impact of coronary artery disease and percutaneous coronary intervention on transcatheter aortic valve implantation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016584/ https://www.ncbi.nlm.nih.gov/pubmed/33824628 http://dx.doi.org/10.1155/2021/6672400 |
work_keys_str_mv | AT mattaanthonyg impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT lhermusierthibault impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT paradafranciscocampelo impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT bouissetfrederic impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT canitrotronan impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT nadervanessa impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT blancostephanie impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT elbazmeyer impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT roncallijerome impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation AT carriedidier impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation |